RankAlpha logo
Back to Rankings

PLYX

Polaryx TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The constructive case is that the May financing bought enough time to reach SOTERIA initiation, and a clean trial launch could re-rate shares toward the May placement range because the platform value is currently being discounted for funding and execution risk. [#8-K-2026-05-28] [#10-K-2026-03-24]
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -1.3.
What can break
Clinical strategy is concentrated in an open-label, multi-indication basket study, which can create execution, recruitment, and interpretability risk before later registrational planning is clearer. [#10-K-2026-03-24]
Momentum
98
Value
46
Sentiment
45
Setup hits (3d)
— · Net —
AI TargetsBase $2.10 · Bull $4.00 · Bear $1.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-11 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net —
Target $8.50
Why
Momentum98 · Δ7d -1.3
Value46 · Δ7d 0.0
Sentiment45 · Δ7d -
So what
Strength-led posture. Favor watchlist adds and disciplined entries.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Momentum · See technicals
Momentum
98
26% active weight
Current posture
7d trendSoftening
Δ7d
-1.3
Δ21d
-
Value
46
39% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-0.7
Sentiment
45
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade B. Momentum 98.3 / Value 46.4 / Sentiment 44.5

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$113.65M
Beta
-
Shares Out
49.85M
P/E (TTM) · Derived
-12.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-20.36
Rev YoY
-
EPS YoY
-49.5%
Gross Margin
-
Op Margin
-
Net Debt
-$5.14M
Current Ratio
3.45
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology